23.11.2012 Views

Strategizing Communication in Commercialization of Biotech ... - isaaa

Strategizing Communication in Commercialization of Biotech ... - isaaa

Strategizing Communication in Commercialization of Biotech ... - isaaa

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

Khondoker M. Nasirudd<strong>in</strong><br />

liv<strong>in</strong>g organisms or by import <strong>of</strong> any such materials. These rules will cover the<br />

biosafety <strong>of</strong> transgenic materials produced <strong>in</strong> the country or those that come<br />

through transboundary movement (Rahman, 1990).<br />

awareness, Perception, and adoption Strategy<br />

<strong>of</strong> gM or <strong>Biotech</strong> Crops<br />

Awareness and extent <strong>of</strong> knowledge on genetic eng<strong>in</strong>eer<strong>in</strong>g, biotechnology,<br />

and GMOs among the people are relatively low. Bangladesh’s National<br />

Biosafety Framework (2006) forwards the need to promote and facilitate<br />

public awareness, education, and participation concern<strong>in</strong>g the “safe transfer,<br />

handl<strong>in</strong>g, and use <strong>of</strong> GMOs <strong>in</strong> relation to the conservation and susta<strong>in</strong>able<br />

use <strong>of</strong> biological diversity and risks concerned with human health.” It also<br />

adds that the public should be consulted regard<strong>in</strong>g decisions about GMOs<br />

and biosafety so that the regulatory system is perceived to be transparent<br />

and that public acceptance may enhance biotechnological development <strong>in</strong><br />

the country.<br />

In 2003, the Bangladesh Rural Advancement Committee (BRAC) conducted a<br />

survey <strong>of</strong> the knowledge, attitude, and perception <strong>of</strong> civil society groups on<br />

rice biotechnology research <strong>in</strong> the country not<strong>in</strong>g that these groups mold<br />

public op<strong>in</strong>ion on various national issues. Earlier, IRRI conducted focus group<br />

discussions to pilot test the survey questionnaire. Respondents <strong>of</strong> the BRAC<br />

survey were classified <strong>in</strong>to three groups: 1) scientists and research leaders<br />

<strong>of</strong> agricultural research and educational <strong>in</strong>stitutions who are expected to be<br />

more knowledgeable about the potential risks and benefits <strong>of</strong> biotechnology<br />

and may be its proponents; 2) managers and senior executives <strong>of</strong> NGOs and<br />

environmental advocacy associations who might have been <strong>in</strong>fluenced by the<br />

on-go<strong>in</strong>g debate <strong>in</strong> the developed countries, and may be the opponents <strong>of</strong><br />

biotechnology; and 3) other civil society groups who may be least exposed<br />

to the debate and may hold a neutral position. N<strong>in</strong>ety-n<strong>in</strong>e percent <strong>of</strong> the<br />

232 respondents reported to have heard about biotechnology while 59% said<br />

they heard about GMOs. About 86% correctly def<strong>in</strong>ed “GMO” as genetically<br />

modified organism.<br />

210<br />

Chapter 9

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!